2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Presidential Session

[PS4] Presidential Session 4
【E】

Sat. Feb 19, 2022 8:20 AM - 9:50 AM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Eishi Baba（Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University），Shingo Yano（Division of Clinical Oncology and Hematology, The Jikei University School of Medicine）
Discussant：Daniel A. Pallyea（Division of Hematology, Department of Medicine, University of Colorado），Kaoru Tanaka（Department of Medical Oncology, Kindai University Faculty of Medicine），Hidekazu Hirano（Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital），Hiroyuki Okuyama（Department of Clinical Oncology, Kagawa University Hospital）

[PS4-3] A phase III trial of pimitespib (TAS-116) in patients with advanced gastrointestinal stromal tumor: CHAPTER-GIST-301

○Akira Sawaki1, Yukinori Kurokawa2, Yoshitaka Honma3, Yoichi Naito4, Shiro Iwagami5, Hideo Baba5, Yoshito Komatsu6, Toshirou Nishida7,8, Toshihiko Doi9 (1.Department of Gastroenterology, Fujita Health University Hospital, 2.Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 3.Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 4.Department of General Internal Medicine, Medical Oncology, Experimental Therapeutics, National Cancer Center Hospital East, 5.Department of Gastroenterological Surgery, Kumamoto University Hospital, 6.Department of Cancer Center, Hokkaido University Hospital, 7.Department of Surgery, National Cancer Center Hospital, 8.Department of Surgery, Japan Community Health Care Organization Osaka Hospital, 9.Department of Experimental Therapeutics, National Cancer Center Hospital East)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password